Seguir
Amanda Cano
Amanda Cano
Ace Alzheimer Center Barcelona
Dirección de correo verificada de fundacioace.org - Página principal
Título
Citado por
Citado por
Año
Metal-based nanoparticles as antimicrobial agents: an overview
E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ...
Nanomaterials 10 (2), 292, 2020
9732020
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
8712022
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ...
Journal of Controlled Release 301, 62-75, 2019
2362019
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization
E Sánchez-López, M Ettcheto, MA Egea, M Espina, A Cano, AC Calpena, ...
Journal of nanobiotechnology 16, 1-16, 2018
2102018
Current applications of nanoemulsions in cancer therapeutics
E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ...
Nanomaterials 9 (6), 821, 2019
1702019
Advanced formulation approaches for ocular drug delivery: state-of-the-art and recent patents
EB Souto, J Dias-Ferreira, A López-Machado, M Ettcheto, A Cano, ...
Pharmaceutics 11 (9), 460, 2019
1562019
PEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen—In vitro, ex vivo and in vivo characterization
E Sánchez-López, MA Egea, A Cano, M Espina, AC Calpena, M Ettcheto, ...
Colloids and surfaces B: biointerfaces 145, 241-250, 2016
1272016
Microemulsions and nanoemulsions in skin drug delivery
EB Souto, A Cano, C Martins-Gomes, TE Coutinho, A Zielińska, AM Silva
Bioengineering 9 (4), 158, 2022
962022
Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases
A Cano, E Sánchez-López, M Ettcheto, A López-Machado, M Espina, ...
Nanomedicine 15 (12), 1239-1261, 2020
832020
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy
A Cano, M Ettcheto, M Espina, C Auladell, AC Calpena, J Folch, ...
Nanomedicine: Nanotechnology, Biology and Medicine 14 (4), 1073-1085, 2018
782018
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
PR Manzine, M Ettcheto, A Cano, O Busquets, E Marcello, S Pelucchi, ...
Biomedicine & Pharmacotherapy 113, 108661, 2019
732019
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
A Cano, P Turowski, M Ettcheto, JT Duskey, G Tosi, E Sánchez-López, ...
Journal of nanobiotechnology 19 (1), 122, 2021
702021
Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery
EB Souto, JF Fangueiro, AR Fernandes, A Cano, E Sanchez-Lopez, ...
Heliyon, 2022
682022
Dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study
E Sánchez-López, G Esteruelas, A Ortiz, M Espina, J Prat, M Muñoz, ...
Nanomaterials 10 (4), 720, 2020
582020
Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe/PS1dE9 mice
M Ettcheto, A Cano, PR Manzine, O Busquets, E Verdaguer, ...
Molecular neurobiology 57, 1814-1827, 2020
562020
The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia
J Folch, J Olloquequi, M Ettcheto, O Busquets, E Sánchez-López, A Cano, ...
Frontiers in aging neuroscience 11, 468958, 2019
542019
Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics
RG Petit, A Cano, A Ortiz, M Espina, J Prat, M Muñoz, P Severino, ...
International journal of molecular sciences 22 (9), 4983, 2021
532021
Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia
M Ettcheto, J Olloquequi, E Sanchez-Lopez, O Busquets, A Cano, ...
Frontiers in aging neuroscience 11, 344, 2020
522020
State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
A Cano, M Ettcheto, M Espina, A López-Machado, Y Cajal, F Rabanal, ...
Journal of nanobiotechnology 18, 1-24, 2020
512020
Elastic and ultradeformable liposomes for transdermal delivery of active pharmaceutical ingredients (APIs)
EB Souto, AS Macedo, J Dias-Ferreira, A Cano, A Zielińska, CM Matos
International Journal of Molecular Sciences 22 (18), 9743, 2021
462021
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20